Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up-Reference-Cited by-同舟云学术

Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up

Published:2023-11-06 Issue:2 Volume:65 Page:228-234
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Khouderchah Christy J.¹^ORCID,Benitez Lydia L.¹²,Marini Bernard L.¹²^ORCID,Fraga Martina¹,Pettit Kristen³⁴,Burke Patrick W.³⁴,Bixby Dale L.³⁴,Perissinotti Anthony J.¹²

Affiliation:

1. Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA

2. University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA

3. Department of Internal Medicine and Division of Hematology and Oncology, Michigan Medicine, Ann Arbor, Michigan, USA

4. University of Michigan Medical School, Ann Arbor, Michigan, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2276056

Reference15 articles.

1. Acute Myeloid Leukemia - Cancer Stat Facts. SEER. Accessed August 17 2022. https://seer.cancer.gov/statfacts/html/amyl.html.

2. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

3. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

4. Venclexta (venetoclax). [package insert]. South San Francisco CA: genentech 2019.

5. Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour lysis syndrome;Nature Reviews Disease Primers;2024-08-22